| Biotechnology Industry | Healthcare Sector | Juan Lopez-Belmonte Encina CEO | XMAD Exchange | ES0157261019 ISIN |
| ES Country | 2,197 Employees | 13 Jul 2026 Last Dividend | - Last Split | - IPO Date |
Laboratorios Farmaceuticos Rovi, S.A. is a Spanish pharmaceutical company with a global reach, specializing in the research, development, manufacturing, and marketing of pharmaceutical products. Established in 1946 and headquartered in Madrid, Spain, the company operates in various therapeutic areas including cardiology, women's health, anesthesia and pain management, diagnostic imaging, and more. Rovi offers a broad range of products aimed at improving patient healthcare across multiple domains. It also extends its expertise to offer contract-manufacturing services, providing a comprehensive suite of pharmaceutical manufacturing solutions ranging from prefilled syringes to sachets. As a subsidiary of Norbel Inversiones, S.L., Rovi continues to expand its product portfolio and technological capabilities, striving to meet the evolving needs of healthcare professionals and patients worldwide.
These are the principal pharmaceutical products offered by Rovi, covering a wide range of medical needs including cardiology, osteoarticular/women's health, anesthesia/pain, central nervous system, urology, endocrinology, respiratory and primary healthcare. Each designed to target specific health conditions, aiding in their treatment and management.
Rovi provides a variety of products specifically designed for hospital use, including diagnostic imaging contrast agents and anticoagulants. These products facilitate a range of medical procedures and treatments, supporting healthcare professionals in providing high-quality care.
In addition to its diverse product lineup, Rovi offers contract-manufacturing services to other pharmaceutical companies. This includes the production of a variety of pharmaceutical forms such as prefilled syringes, vials, suppositories, tablets, and sachets. Through these services, Rovi leverages its manufacturing capabilities and expertise to support the wider pharmaceutical industry.